To understand the difference between these medications, let’s start with understanding GLP-1, the general name given to these types of medications:
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino-acid-long peptide hormone. It is produced and secreted by the body upon food consumption. GLP-1 has the ability to decrease blood sugar levels in a glucose-dependent manner by enhancing the secretion of insulin. Thus, it has been used for years in patients with type 2 diabetes. However, because GLP-1-based treatment has been associated with weight loss and a lower risk of hypoglycemia, certain GLP-1 agonist medications have been approved by the FDA for weight loss treatments and chronic weight loss management. GLP-1 has also shown signs of carrying out protective and regulatory effects in numerous other tissues, including heart, tongue, adipose, muscles, bones, kidneys, liver, and lungs.
What is the difference between Semaglutide and Ozempic®, Rybelsus®, and Wegovy®?
Semaglutide is a GLP-1 receptor agonist and is the generic name of the primary active ingredient in the brand name medications Ozempic®, Wegovy®, and Rybelsus®. The main differences between these brands are that Ozempic® and Wegovy® are offered in an injectable form and Rybelsus® is offered as an oral medication. These brand name medications can be significantly more expensive than the generic form of the same medication, semaglutide, which is only available through medical clinics that work directly with reputable U.S. based pharmacies, such as Balanced Medical Solutions.
Semaglutide has been used for years to treat Type 2 diabetes, and was recently approved by the FDA for chronic weight management for non-diabetic patients. Studies show it has resulted in an average of 15% of weight loss in clinic trials. It can be used by most patients as a one-time treatment to lose unwanted weight, but it is also approved to help with long-term waste management under the care of a medical provider. Semaglutide has been studied for over five years and is proven safe and effective both for individuals with type 2 diabetes and for those with obesity or who are overweight.
What is the difference between semaglutide and Mounjaro®, ZepBound®, and Trulicity®?
Semaglutide, Mounjaro®, Zepbound®, and Trulicity® are injectable medications that work on hormones involved in blood sugar regulation, appetite, and food intake. Semaglutide and Trulicity® (dulaglutide) are GLP-1 receptor agonists, while Mounjaro® and Zepbound® (tirzepatide) activate two pathways – GLP-1 and GIP. Semaglutide is available under different brand names, including Wegovy® for chronic weight management and Ozempic® for type 2 diabetes. Mounjaro® is approved for type 2 diabetes, while Zepbound® is approved for chronic weight management and certain adults with obesity and moderate-to-severe obstructive sleep apnea. Trulicity® is primarily used to treat type 2 diabetes.
The medications differ in their active ingredients, mechanisms of action, FDA-approved uses, dosing, and individual response. Tirzepatide’s dual GLP-1/GIP action can produce substantial weight loss, while semaglutide is also an effective weight-management medication for approximately 85% of patients. The right medication and dose depend on an individual’s medical history, goals, other medications, and response to treatment and should be determined with a qualified healthcare provider.
Are YOU ready to lose that unwanted weight once and for all?
At Balanced Medical Solutions we see you as the unique and whole individual that you are and work to find the root causes of your weight gain. We aim to provide you with the best treatment options for YOU, based on a comprehensive evaluation, which we offer for only $99 (valued at $800+). This includes labs, a medical consultation with a specialist and free follow-up office visits for life. And of course, we monitor you every step of the way on your journey to make sure you are seeing positive results.
